Status:
COMPLETED
L-Arginine, Vascular Response and Mechanisms
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Hypertension
Diabetes
Eligibility:
All Genders
70+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to employ the supplement L-arginine to test the hypothesis that activation of blood flow to the brain during cognitive tasks is regulated by nitric oxide in older subjects ...
Eligibility Criteria
Inclusion
- diabetes and/or hypertension
Exclusion
- alzheimers disease, dementia, stroke, active herpes, recent angina or heart attack
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01482247
Start Date
April 1 2012
End Date
January 1 2014
Last Update
July 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115